| Literature DB >> 36071086 |
Pedro de Barros E Silva1, Marco Antonio Praça Oliveira2, Marcelo Arruda Nakazone3, Marcos Gradim Tiveron4, Valquíria Pelliser Campagnucci5, Bianca Maria Maglia Orlandi6,7, Omar Asdrúbal Vilca Mejia8,9, Jennifer Loría Sorio10,11, Luiz Augusto Ferreira Lisboa6, Jorge Zubelli12, Sharon-Lise Normand7,13, Fabio Biscegli Jatene6.
Abstract
Clinical prediction models for deep sternal wound infections (DSWI) after coronary artery bypass graft (CABG) surgery exist, although they have a poor impact in external validation studies. We developed and validated a new predictive model for 30-day DSWI after CABG (REPINF) and compared it with the Society of Thoracic Surgeons model (STS). The REPINF model was created through a multicenter cohort of adults undergoing CABG surgery (REPLICCAR II Study) database, using least absolute shrinkage and selection operator (LASSO) logistic regression, internally and externally validated comparing discrimination, calibration in-the-large (CL), net reclassification improvement (NRI) and integrated discrimination improvement (IDI), trained between the new model and the STS PredDeep, a validated model for DSWI after cardiac surgery. In the validation data, c-index = 0.83 (95% CI 0.72-0.95). Compared to the STS PredDeep, predictions improved by 6.5% (IDI). However, both STS and REPINF had limited calibration. Different populations require independent scoring systems to achieve the best predictive effect. The external validation of REPINF across multiple centers is an important quality improvement tool to generalize the model and to guide healthcare professionals in the prevention of DSWI after CABG surgery.Entities:
Mesh:
Year: 2022 PMID: 36071086 PMCID: PMC9452524 DOI: 10.1038/s41598-022-19473-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Baseline characteristics of patients undergoing isolated CABG surgery with and without DSWI (n = 4085). REPLICCAR II, São Paulo, Brazil, 2017–2019.
| DSWI | ||||
|---|---|---|---|---|
| Yes (n = 101) | No (n = 3984) | |||
| n | % | n | % | |
| Age (years)a | 63.6 ± 9.5 | 63.2 ± 9.2 | ||
| Gender male | 50 | 49.5 | 2984 | 74.9 |
| BMI (kg/m2)a | 29 ± 5.5 | 27.4 ± 4.3 | ||
| Diabetes | 72 | 71.3 | 1938 | 48.6 |
| Hemoglobin (mg/dL)a | 12.6 ± 1.86 | 13.5 ± 1.79 | ||
| Hematocrit (%)a | 38 ± 5.1 | 40 ± 4.9 | ||
| NYHA ≥ III | 3 | 3.0 | 140 | 3.5 |
| Three-vessel disease | 15 | 14.9 | 1060 | 26.6 |
| Elective | 54 | 53.5 | 2600 | 65.3 |
| Urgency | 43 | 42.6 | 1371 | 34.4 |
| Emergency | 4 | 4.0 | 13 | 0.3 |
| Lowest intraoperative temperature (°C)a | 33.2 ± 1.9 | 33.8 ± 1.9 | ||
| Surgery duration (hours)a | 5.9 ± 1.7 | 4.7 ± 1.6 | ||
| CPB time (minutes)a | 87.1 ± 31.6 | 75.5 ± 29.2 | ||
| Anoxia time (minutes)a | 69.8 ± 30.8 | 58.4 ± 24.8 | ||
| BITA | 19 | 18.8 | 450 | 11.3 |
| Intraoperative high glucose (mg/dL)a | 205.1 ± 61.4 | 179.6 ± 59.9 | ||
| Intraoperative blood transfusion | 30 | 29.7 | 700 | 17.6 |
BMI: body mass index; MI: myocardial infarction; NYHA: New York Heart Association; CPB: cardiopulmonary bypass; BITA: bilateral internal thoracic artery.
aMean ± SD.
LASSO logistic regression tenfold cross-validation coefficients. REPINF, REPLICCAR II, São Paulo, Brazil, 2017–2019.
| Covariates | Coefficients | Logistic regression standard error |
|---|---|---|
| Female gender | 0.246 | 0.267 |
| Body mass index | 0.041 | 0.025 |
| Diabetes | 0.134 | 0.279 |
| Hemoglobin | − 0.182 | 0.236 |
| Surgery emergency status | 0.132 | 0.793 |
| Surgery duration | 0.433 | 0.091 |
| Bilateral internal thoracic artery used | 0.020 | 0.308 |
| Constant | − 3851 | – |
Figure 1Receiver operating characteristic curve (ROC; c-index) in the external validation sample of the REPINF and STS in patients undergoing isolated CABG. Sao Paulo, Brazil, 2017–2019.
Figure 2Calibration in-the-large plot on training and external validation. REPINF, Sao Paulo, Brazil, 2017–2019.
Reclassification data table with quintiles for net reclassification improvement (NRI). REPINF, REPLICCAR II, São Paulo, Brazil, 2017–2019.
| Event | REPINF | |||||||
|---|---|---|---|---|---|---|---|---|
| Quintile | 1 | 2 | 3 | 4 | 5 | Total | ||
| No | STS | 1 | 379 | 217 | 138 | 67 | 36 | 837 |
| 2 | 223 | 221 | 175 | 137 | 63 | 819 | ||
| 3 | 128 | 181 | 172 | 184 | 123 | 788 | ||
| 4 | 71 | 132 | 203 | 187 | 186 | 779 | ||
| 5 | 16 | 57 | 122 | 224 | 342 | 761 | ||
| 817 | 808 | 810 | 799 | 750 | 3984 | |||
| Yes | STS | 1 | 0 | 2 | 3 | 1 | 2 | 8 |
| 2 | 0 | 3 | 0 | 4 | 6 | 13 | ||
| 3 | 0 | 2 | 2 | 2 | 6 | 12 | ||
| 4 | 0 | 1 | 0 | 4 | 16 | 21 | ||
| 5 | 0 | 1 | 2 | 7 | 37 | 47 | ||
| Total | 0 | 9 | 7 | 18 | 67 | 101 | ||
Comparison of baseline characteristics of STS, REPINF and EuroSCORE II models, São Paulo, Brazil, 2017–2019.
| Score | STS | REPINF | EuroSCORE II |
|---|---|---|---|
| Timeframe for data collection | Jan 2002–Dez 2006 | Aug 2017–Jul 2019 | 12 weeks (May–Jun 2010) |
| Study population | 774,881 isolated CABG procedures | 4085 isolated CABG procedures | 22,381 major cardiac procedures |
| Multicentric | Yes, 819 participating centers | Yes, 7 participating centers | Yes, 154 participating centers |
| Statistical approach | Regression modeling | LASSO regression | Multivariate Logistic Regression |
| Outcome | Mortality (operative and in-hospital) | DSWI (30 days after surgery) | Mortality at the base hospital |
| Secondary outcomes | Renal failure, stroke, reoperation for any cause, prolonged ventilation, deep sternal wound infection, composite major morbidity or mortality, prolonged length of stay (> 14 days), and short length of stay (< 6 days and alive) | No | Mortality at 30 and 90 days |
| Discrimination DSWI (c- index) | Yes, STS PredDeep (c-index training: 0.71 and validation: 0.69) | Yes, REPINF (c-index training: 0.81 and validation: 0.83) | No |